Dual effects of phenylalanine analogs on rabbit-muscle pyruvate kinase activity. 1981

E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman

Rabbit muscle pyruvate kinase activity has been studied in the presence of L-phenylalanine and its analogs: L-phenylalanyl methyl ester (PheOMe), L-1-amino-2-phenylethyl phosphonic acid (PnPhe), L-alanine and L-1-aminoethyl phosphonic acid (PnAla). At appropriate pH and substrate concentrations all the analogs and Phe exhibited activatory and inhibitory effects at low (1--5 mM) and at high (above 5mM) ligand concentrations respectively. Activation of pyruvate kinase by Phe and PheOMe was observed at pH above 8.2 in the presence of 2.5 mM ADP and 0.5 mM phosphoenolpyruvate (P-pyruvate), while PnPhe activation was also observed at pH 7.5. The activatory effect followed the order: PnPhe much greater than Phe greater than PheOMe. All the effectors showed a mixed type of inhibition or activation with P-pyruvate as a variable substrate and a non-competitive inhibition or activation with ADP as a variable substrate.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D011770 Pyruvate Kinase ATP:pyruvate 2-O-phosphotransferase. A phosphotransferase that catalyzes reversibly the phosphorylation of pyruvate to phosphoenolpyruvate in the presence of ATP. It has four isozymes (L, R, M1, and M2). Deficiency of the enzyme results in hemolytic anemia. EC 2.7.1.40. L-Type Pyruvate Kinase,M-Type Pyruvate Kinase,M1-Type Pyruvate Kinase,M2-Type Pyruvate Kinase,Pyruvate Kinase L,R-Type Pyruvate Kinase,L Type Pyruvate Kinase,M Type Pyruvate Kinase,M1 Type Pyruvate Kinase,M2 Type Pyruvate Kinase,Pyruvate Kinase, L-Type,Pyruvate Kinase, M-Type,Pyruvate Kinase, M1-Type,Pyruvate Kinase, M2-Type,Pyruvate Kinase, R-Type,R Type Pyruvate Kinase
D011773 Pyruvates Derivatives of PYRUVIC ACID, including its salts and esters.
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
July 1971, Biochemistry,
E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
February 1981, Canadian journal of biochemistry,
E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
August 1975, The Journal of biological chemistry,
E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
October 1982, Bioscience reports,
E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
January 2005, Nucleosides, nucleotides & nucleic acids,
E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
December 1990, Biochemistry,
E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
February 1972, Biochemistry,
E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
December 1970, FEBS letters,
E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
March 1996, The Journal of biological chemistry,
E Izbicka-Dimitrijević, and P Mastalerz, and M Kochman
January 2003, Biophysical chemistry,
Copied contents to your clipboard!